RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
Neurelis Inc Neuroscience company. Series D USD 114,000,000
3-V Biosciences Inc Biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases. Series B USD 30,000,000
Vyome Biosciences Pvt Ltd Developer of medicines for treating skin diseases caused by resistant microbes. Series C USD 14,000,000
Arcis Biotechnology Holdings Ltd N/A GBP 2,500,000
FunkSac LLC Provider of customer services and compliant packaging solutions for the legal cannabis industry; both medical and recreational markets. N/A
23andMe Inc DNA testing and genome sequencing firm. Series E USD 79,100,000
3SBio Inc IPO HKD 5,510,000,000
23andMe Inc DNA testing and genome sequencing firm. Grant USD 1,400,000
Arecor Ltd Developed a unique technology that is used in the formulation of biopharmaceuticals. N/A
Zosano Pharma Inc Debt USD 3,030,000

BEST FUNDED STARTUPS


Biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases.

Personalized medicine company specializing in pharmacogenetics

Developer of prostate cancer drugs

Advanced fight against drug resistant microbes by attacking novel targets with novel drugs.

Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases.

Developer of small molecule therapeutics for the treatment of inflammatory disease

Developer of products that penetrate the mucosal barrier to treat a variety of severe diseases

Developer of medicines for treating skin diseases caused by resistant microbes.

Pharmaceutical firm developing porous micro-particle delivery systems.

Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction

Develop and market niche pharmaceutical products

Focusing on the discovery and development of innovative drugs targeting epigenetic enzymes, in particular histone methyltransferases (HMTs).